EP4739693A2 - Verbessertes herstellungsverfahren und zwischenprodukte für eine pyrrolo[2,3-d pyrimidinverbindung und verwendung davon - Google Patents

Verbessertes herstellungsverfahren und zwischenprodukte für eine pyrrolo[2,3-d pyrimidinverbindung und verwendung davon

Info

Publication number
EP4739693A2
EP4739693A2 EP24745521.5A EP24745521A EP4739693A2 EP 4739693 A2 EP4739693 A2 EP 4739693A2 EP 24745521 A EP24745521 A EP 24745521A EP 4739693 A2 EP4739693 A2 EP 4739693A2
Authority
EP
European Patent Office
Prior art keywords
acid salt
salt
acid
sulfonamide
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24745521.5A
Other languages
English (en)
French (fr)
Inventor
Declan Thomas Patrick CUSACK
Jacob Cole DEFOREST
Srinivas Reddy Dubbaka
Padraig Mary O'neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ireland Pharmaceuticals Unlimited Co
Original Assignee
Pfizer Ireland Pharmaceuticals Unlimited Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals Unlimited Co filed Critical Pfizer Ireland Pharmaceuticals Unlimited Co
Publication of EP4739693A2 publication Critical patent/EP4739693A2/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP24745521.5A 2023-07-06 2024-07-03 Verbessertes herstellungsverfahren und zwischenprodukte für eine pyrrolo[2,3-d pyrimidinverbindung und verwendung davon Pending EP4739693A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363512136P 2023-07-06 2023-07-06
PCT/IB2024/056518 WO2025008772A2 (en) 2023-07-06 2024-07-03 Improved manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof

Publications (1)

Publication Number Publication Date
EP4739693A2 true EP4739693A2 (de) 2026-05-13

Family

ID=91959179

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24745521.5A Pending EP4739693A2 (de) 2023-07-06 2024-07-03 Verbessertes herstellungsverfahren und zwischenprodukte für eine pyrrolo[2,3-d pyrimidinverbindung und verwendung davon

Country Status (3)

Country Link
EP (1) EP4739693A2 (de)
CN (1) CN121443612A (de)
WO (1) WO2025008772A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3290421B1 (de) * 2013-02-22 2019-01-02 Pfizer Inc Kombination aus pyrrolo[2, 3 -d]pyrimidinderivaten und einem oder mehreren zusätzlichen wirkstoffen als inhibitoren von janus kinasen (jak)
GB201509885D0 (en) * 2015-06-08 2015-07-22 Ucb Biopharma Sprl Therapeutic agents

Also Published As

Publication number Publication date
WO2025008772A2 (en) 2025-01-09
WO2025008772A3 (en) 2025-02-27
CN121443612A (zh) 2026-01-30

Similar Documents

Publication Publication Date Title
AU707075B2 (en) Carbocyclic intermediates and process of manufacture thereof
CA2699438C (en) Method for preparing disubstituted piperidine and intermediates
ES2890492T3 (es) Métodos para preparar N-(4-fluorobencil)-N-(1-metilpiperidin-4-il)-N'-(4-(2-metilpropiloxi)fenilmetil)carbamida y su sal de tartrato y forma polimórfica C
AU2005289635A2 (en) Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide and their preparation
US9862718B2 (en) Sodium salt of (2S, 5R)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1] octane-2-carboxylic acid and its preparation
WO2011045702A1 (en) Pyrrolo[2,3-d] pyrimidine compounds
NZ571142A (en) Synthesis of acylaminoalkenylene amides such as (4R)-4-[N'-methyl-N'-(3,5-bistrifluoromethyl-benzoyl)-amino]-4(-3,4-dichlorobenzyl)-but-2-enoic acid N-[(R)-epsilon-caprolactam-3-yl]-amide hemihydrate useful as substance P antagonists
EP2938616A1 (de) Verarbeitungsverfahren zur herstellung von tofacitinib und zwischenprodukten davon
KR102384529B1 (ko) 4-알콕시-3-(아실 또는 알킬)옥시피콜린아미드의 제조 방법
CA3188344A1 (en) Preparation of a pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone derivative and salt thereof
EP2611776B1 (de) Herstellungsverfahren für eine intermediatverbindung zur synthese eines medikaments
EP3412666A1 (de) Verfahren und zwischenprodukte zur herstellung von bcl-2-hemmern mit venetoclax durch reduktive animation
EP3091007A1 (de) Verfahren zur herstellung von piperidinverbindungen
JP5977289B2 (ja) イソキノリン誘導体又はその塩の新規製造方法
CA2860810A1 (en) (3,4-dichloro-phenyl)-((s)-3-propyl-pyrrolidin-3-yl)-methanone hydrochloride and manufacturing processes
WO2025008772A2 (en) Improved manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof
JPWO2006129626A1 (ja) ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
WO2014083571A1 (en) A process for the preparation of alcaftadine
AU1947100A (en) Process for preparing growth hormone secretagogues
US9604986B2 (en) Polymorphs and process for preparation of (2S, 5R)-7-oxo-N-[(2S)-pyrrolidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
SK16332002A3 (sk) Spôsob prípravy bifenylových zlúčenín
KR102811620B1 (ko) 1,4-디아조칸 화합물 또는 이의 염
KR102748251B1 (ko) 리나글립틴 및 이의 염의 제조를 위한 중간체 및 방법
US20120041211A1 (en) Novel process for preparing carboxy-containing pyrazoleamido compounds 597
US12459948B2 (en) Processes and intermediates for preparing a Btk inhibitor

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20260206

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR